Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

1.

Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin.

Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ, Whitington PF.

J Pediatr. 2009 Oct;155(4):566-71. doi: 10.1016/j.jpeds.2009.04.012. Epub 2009 Jun 28.

PMID:
19560784
2.

Neonatal hemochromatosis: long-term experience with favorable outcome.

Grabhorn E, Richter A, Burdelski M, Rogiers X, Ganschow R.

Pediatrics. 2006 Nov;118(5):2060-5.

PMID:
17079579
3.

Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin.

Whitington PF, Kelly S.

Pediatrics. 2008 Jun;121(6):e1615-21. doi: 10.1542/peds.2007-3107. Epub 2008 May 12.

PMID:
18474533
4.

Successful management of neonatal hemochromatosis by exchange transfusion and immunoglobulin: a case report.

Babor F, Hadzik B, Stannigel H, Mayatepek E, Hoehn T.

J Perinatol. 2013 Jan;33(1):83-5. doi: 10.1038/jp.2012.9.

PMID:
23269232
5.

High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.

Yip LW, Thong BY, Tan AW, Khin LW, Chng HH, Heng WJ.

Eye (Lond). 2005 Aug;19(8):846-53. Review.

PMID:
15389280
6.

Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.

Elalfy MS, Elbarbary NS, Abaza HW.

Eur J Pediatr. 2011 Apr;170(4):461-7. doi: 10.1007/s00431-010-1310-8. Epub 2010 Oct 6.

PMID:
20924607
7.

Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.

Walsh SA, Yao N, El-Khuffash A, Twomey A, Molloy EJ.

Ir Med J. 2008 Feb;101(2):46-8.

PMID:
18450249
8.

Is exchange transfusion a possible treatment for neonatal hemochromatosis?

Timpani G, Foti F, Nicolò A, Nicotina PA, Nicastro E, Iorio R.

J Hepatol. 2007 Nov;47(5):732-5. Epub 2007 Aug 30.

PMID:
17869371
9.

Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice.

Ergaz Z, Arad I.

J Perinat Med. 1993;21(3):183-7.

PMID:
8229608
10.

Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.

Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.

J Matern Fetal Neonatal Med. 2004 Sep;16(3):163-6.

PMID:
15590442
11.

Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.

Nasseri F, Mamouri GA, Babaei H.

Saudi Med J. 2006 Dec;27(12):1827-30.

PMID:
17143357
12.
13.

Medical and surgical treatment of neonatal hemochromatosis: single center experience.

Heffron T, Pillen T, Welch D, Asolati M, Smallwood G, Hagedorn P, Fasola C, Solis D, Rodrigues J, DePaolo J, Spivey J, Martinez E, Henry S, Romero R.

Pediatr Transplant. 2007 Jun;11(4):374-8.

PMID:
17493216
14.

Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.

Demirel G, Akar M, Celik IH, Erdeve O, Uras N, Oguz SS, Dilmen U.

Int J Hematol. 2011 Jun;93(6):700-3. doi: 10.1007/s12185-011-0853-4. Epub 2011 May 25.

PMID:
21617887
15.

Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.

Tufan F, Kamali S, Erer B, Gul A, Inanc M, Ocal L, Konice M, Aral O.

Clin Rheumatol. 2007 Nov;26(11):1913-5. Epub 2007 Jul 18.

PMID:
17636363
16.

[Prophylactic prenatal therapy with intravenous immunoglobulins for patients at risk for neonatal haemochromatosis].

Faas D, Axt-Fliedner R, Zimmer KP, Heckmann M.

Z Geburtshilfe Neonatol. 2011 Dec;215(6):246-9. doi: 10.1055/s-0031-1291215. Epub 2012 Jan 24. German.

PMID:
22274935
17.

[Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].

Léger JM, Viala K, Maisonobe T, Bouche P.

Bull Acad Natl Med. 2007 Oct;191(7):1395-407; discussion 1407-9. French.

PMID:
18447061
18.

IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders.

Fillit H, Hess G, Hill J, Bonnet P, Toso C.

Neurology. 2009 Jul 21;73(3):180-5. doi: 10.1212/WNL.0b013e3181ae7aaf.

PMID:
19620605
19.

Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.

Shahgholi E, Vosough P, Sotoudeh K, Arjomandi K, Ansari S, Salehi S, Faranoush M, Ehsani MA.

Indian J Pediatr. 2008 Dec;75(12):1231-5. doi: 10.1007/s12098-008-0243-y. Epub 2009 Feb 4.

PMID:
19190878
20.

Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg.

Ravaglia S, Piccolo G, Ceroni M, Franciotta D, Pichiecchio A, Bastianello S, Tavazzi E, Minoli L, Marchioni E.

J Neurol. 2007 Nov;254(11):1518-23. Epub 2007 Nov 14.

PMID:
17965959

Supplemental Content

Support Center